Latest HIV Drug Stories
PARIS, April 13, 2015 /PRNewswire/ -- Novel mechanism of action - prevention of viral RNA exit from nucleus of infected cells - associated to unique anti-viral properties
The psychoactivity of an antiretroviral drug commonly used to treat HIV has been linked to its recreational use, according to research presented during the Experimental Biology 2013 conference in Boston, Massachusetts on Sunday.
The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing.
A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus (HPV), say scientists.
Novel HIV Drug to be Studied in Cell Cultures and in Patients PHILADELPHIA, Oct.
Focusing HIV drug development on immune cells called macrophages instead of traditionally targeted T cells could bring us closer to eradicating the disease, according to new research from University of Florida and five other institutions.
Nature study reveals long-sought atomic structure of key enzyme and suggests new approach for drug development.
MELVILLE, N.Y. _ A drug that zeros in on a novel HIV target and disables a key link in the infection process can successfully treat patients who have failed other therapies, Stony Brook University doctors have found. Dr.
Samaritan Pharmaceuticals (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, announced that it has filed an IND (Investigational New Drug) application for SP-6310 in the treatment of HIV-infected patients with abnormal cortisol levels.
NanoViricides has said that its lead anti-HIV drug candidate demonstrated markedly superior survival results in the test animals when compared to those animals given the anti-HIV 'combo cocktail' in a double-blind animal study.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.